AI/ML Innovations Inc. Completes Acquisition of Technology from Naiad Lab Inc

VICTORIA, BC / ACCESSWIRE / August 23, 2024 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced the completion of its acquisition of technology from Naiad Lab Inc. The leading company, committed to advancing AI and machine learning technologies to address societal needs, issued a total of 6,700,000 shares at $0.05 per share to Naiad Lab Inc.

As per the agreement, the common shares issued are subject to a twelve-month voluntary hold period. This acquisition aligns with AI/ML Innovations' strategic focus on digital health and wellbeing sectors that leverage AI, ML, cloud computing, and digital platforms for healthcare solutions.

The company's strategic partnerships extend to firms like Health Gauge Inc. and AI Rx Inc., supporting their growth in AI-driven healthcare advancements. AI/ML Innovations trades on multiple exchanges, including the Canadian Securities Exchange, OTCQB Venture Market, and the Frankfurt Stock Exchange.